Search results for "antico"

showing 10 items of 736 documents

Dante: una prospettiva linguistica

2021

Una riconsiderazione del legato delle opere di Dante Alighieri da una prospettiva che valorizza, sotto diverse angolature, il suo impegno nella costruzione di una lingua letteraria per la prosa, oltre che in quella di una lingua letteraria per la "rima", come il poeta fiorentino designava la poesia.

Lingua letteraria Italiano antico Dante Alighieri Il Convivio De Vulgari Eloquentia Questione della linguaSettore L-LIN/01 - Glottologia E Linguistica
researchProduct

Verb inflection in Ancient Greek and Sanskrit and auxiliation patterns in French and Italian. Forms, functions, system

2009

This paper deals with the complex interaction between form and function in the verb morphosyntax of four Indo-European languages (French, Italian, Ancient Greek and Sanskrit). Beyond the difference in form, auxiliation patterns in French and Italian, and verb inflections in Ancient Greek and Sanskrit correlate, thanks to the agreement for number and person, to the expression of the relationship with the Subject. The different auxiliation patterns (sum and habeo) and the different inflections (middle and active) correlate to different properties of the Subject. In particular, these forms depend on the syntactic opposition between middle and non-middle. The ways of this dependency are regulat…

Linguistics and LanguageHistory470 Latin & Italic languagesVerb410 LinguisticsAncient GreekSettore L-LIN/01 - Glottologia E Linguisticasintassi morfo-sintassi ausiliazione francese italiano greco antico sanscritoForm and functionInflectionSanskritLiteraturebusiness.industryIndo-European languagesFrench800 Literature rhetoric & criticismLinguisticslanguage.human_language3310 Linguistics and LanguageIf and only if460 Spanish & Portuguese languageslanguage450 Italian Romanian & related languagesbusiness440 French & related languages10103 Institute of Romance Studies
researchProduct

Endothelialization and Anticoagulation Potential of Surface-Modified PET Intended for Vascular Applications.

2018

In vascular tissue engineering, great attention is paid to the immobilization of biomolecules onto synthetic grafts to increase bio- and hemocompatibility-two critical milestones in the field. The surface modification field of poly(ethylene terephthalate) (PET), a well-known vascular-graft material, is matured and oversaturated. Nevertheless, most developed methods are laborious multistep procedures generally accompanied by coating instability or toxicity issues. Herein, a straightforward surface modification procedure is presented engineered to simultaneously promote surface endothelialization and anticoagulation properties via the covalent immobilization of gelatin through a photoactivate…

LipopolysaccharidesPolymers and PlasticsPoly(ethylene terephthalate)Gene ExpressionBiocompatible Materials02 engineering and technology01 natural sciencesGelatinendothelializationchemistry.chemical_compoundCoatingPolyethylene terephthalateMaterials Chemistrychemistry.chemical_classificationPolyethylene TerephthalatesSurface modifiedhemocompatibility021001 nanoscience & nanotechnologyPlatelet Endothelial Cell Adhesion Molecule-10210 nano-technologyE-Selectinbiotechnologyendotoxin contentazide photograftingAzidesfood.ingredientMaterials scienceBiocompatibilityCell SurvivalSurface PropertiesBioengineeringengineering.material010402 general chemistryBiomaterialsfoodvon Willebrand FactorHuman Umbilical Vein Endothelial CellsHumansTissue EngineeringBiomoleculeAnticoagulants0104 chemical sciencesBlood Vessel ProsthesischemistryengineeringSurface modificationBlood VesselsGelatinAzideBiomarkersBiomedical engineeringMacromolecular bioscience
researchProduct

Heparin modulates the cellular uptake of nanomedicines

2021

Liposomal formulations are used to improve the safety and cellular absorption of conventional drugs by limiting their interaction with phagocytes. The uptake behaviour of these nanocarriers is affected by the blood composition, and accordingly the presence of an anticoagulant in the blood could have a critical impact on the efficiency of nanomedicines. For the negatively charged liposomes, such as AmBisome®, no significant change in the uptake could be observed when co-incubated with heparin and primary phagocytes. Yet, we observed that a peak of the uptake extent of cationic liposomes was reached at a clinically relevant concentration of heparin for phagocytes and cancer cells. Hence, we r…

Liposomemedicine.drug_classChemistryHeparinAnticoagulantBiomedical EngineeringAnticoagulantsAbsorption (skin)HeparinPharmacologyNanomedicineCationsCancer cellLiposomesmedicineNanomedicineHumansGeneral Materials ScienceCationic liposomeNanocarriersmedicine.drug
researchProduct

Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference.

2016

Abstract Patients with cirrhosis present with hemostatic alterations secondary to reduced availability of pro-coagulant and anti-coagulant factors. The net effect of these changes is a rebalanced hemostatic system. The Italian Association of the Study of the Liver (AISF) and the Italian Society of Internal Medicine (SIMI) promoted a consensus conference on the hemostatic balance in patients with cirrhosis. The consensus process started with the review of the literature by a scientific board of experts and ended with a formal consensus meeting in Rome in December 2014. The statements were graded according to quality of evidence and strength of recommendations, and approved by an independent …

Liver CirrhosisCirrhosisBleeding; Cirrhosis; Hemostasis; Thrombosis; Hepatology; GastroenterologySettore MED/09 - Medicina InternaBleeding; Cirrhosis; Hemostasis; Thrombosis; Anticoagulants; Coagulants; Drug Monitoring; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Postoperative Hemorrhage; Thrombosis; Blood Coagulation Tests; Hemostasis; Hepatology; Gastroenterology0302 clinical medicineEsophageal and Gastric VariceBlood coagulation testConsensus conferenceGastroenterologyThrombosisOptimal managementCirrhosisCoagulant030220 oncology & carcinogenesisThrombosi030211 gastroenterology & hepatologyBlood Coagulation TestsDrug MonitoringGastrointestinal HemorrhageHumanmedicine.medical_specialtyLiver CirrhosiBleeding; Cirrhosis; Hemostasis; Thrombosis; Gastroenterology; HepatologyPostoperative HemorrhageEsophageal and Gastric VaricesNO03 medical and health sciencesInternal medicinemedicineHumansIn patientIntensive care medicineHemostasisCirrhosiHepatologybusiness.industryCoagulantsBleeding; Cirrhosis; Hemostasis; ThrombosisBleedingAnticoagulantAnticoagulantsThrombosisHepatologyHemostasiBlood Coagulation Testmedicine.diseaseSurgeryHemostasisbusinessDigestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
researchProduct

Coagulation and fibrosis in chronic liver disease.

2008

In the hepatic tissue repair mechanism, hepatic stellate cells (HSCs) are recruited at the site of injury and their changes reflect paracrine stimulation by all neighbouring cell types, including sinusoidal endothelial cells, Kupffer cells, hepatocytes, platelets and leucocytes. Thrombin converts circulating fibrinogen to fibrin, promotes platelet aggregation, is a potent activator of endothelial cells, acts as a chemoattractant for inflammatory cells and is a mitogen and chemoattractant for fibroblasts and vascular smooth muscle cells. Most of the cellular effects elicited by thrombin are mediated via a family of widely expressed G-protein-coupled receptors termed protease activated recept…

Liver CirrhosisMaleKupffer CellsReceptors Proteinase-ActivatedThrombin liver fibrosisProteinase-ActivatedChronic liver diseaseFibrinLiver diseaseThrombinFibrosisReceptorsHepatic Stellate CellsmedicineAnimalsHumansPlateletReceptorBlood CoagulationWound HealingAnimals; Anticoagulants; Blood Coagulation; Chronic Disease; Disease Progression; Endothelial Cells; Female; Hepatic Stellate Cells; Hepatocytes; Humans; Kupffer Cells; Liver Cirrhosis; Liver Diseases; Male; Rats; Receptors Proteinase-Activated; Receptors Thrombin; Thrombin; Wound Healing; Gastroenterologybiologybusiness.industryLiver DiseasesThrombinGastroenterologyAnticoagulantsEndothelial Cellsmedicine.diseaseRatsChronic DiseaseImmunologyDisease ProgressionHepatocytesbiology.proteinHepatic stellate cellCancer researchFemaleReceptors Thrombinbusinessmedicine.drug
researchProduct

Beyond subsistence? Settlement strategies of the Late Chalcolithic period in the Selevani Plain (Upper Iraqi Tigris)

2022

The aim of this paper is to provide an integrated overview of the settlement and social dynamics present in the upper sector of the Iraqi Tigris River Valley and its immediate hinterland during the Late Chalcolithic period. This has been achieved by processing and interpreting the results of two extensive regional survey projects, namely the Eastern Ḫabur Archaeological Survey (EHAS) and the Land of Nineveh Archaeological Project (LoNAP), recently undertaken along the eastern bank of the river. These results mark a significant advancement in the study of settlement patterns and cultural history compared to what was previously known of this region, which was mostly terra incognita prior to t…

LoNAPLate ChalcolithicEHASSettore L-OR/05 - Archeologia E Storia Dell'Arte Del Vicino Oriente AnticoIraki KurdistanUruk phoenomenon
researchProduct

A new pro-thrombotic mechanism of neutrophil extracellular traps in antiphospholipid syndrome: impact on activated protein C resistance

2021

Abstract Objectives In APS, precise evaluation of thrombotic risk is a major challenge. Different players, such as activated protein C (APC) resistance or neutrophil extracellular traps (NETs) contribute to the risk of thrombosis. Nevertheless, no study has investigated the interaction between these actors. The main objective of this study was to investigate the relation between NETs and APC resistance. Methods We designed a cross-sectional study including APS/antiphospholipid antibodies (aPL) patients and patients with autoimmune diseases (AID). We performed thrombin generation tests without and with APC to determine APC resistance. To evaluate circulating NETs, we measured plasma levels o…

Lupus anticoagulantbiologybusiness.industryThrombosisNeutrophil extracellular trapsAntiphospholipid Syndromemedicine.diseaseExtracellular TrapsThrombosisCross-Sectional StudiesRheumatologyAntiphospholipid syndromeImmunologyAntithromboticmedicinebiology.proteinHumansPharmacology (medical)AntibodyActivated protein C resistancebusinessProtein CActivated Protein C Resistancemedicine.drugRheumatology
researchProduct

Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism

2013

BackgroundWhether the oral factor Xa inhibitor edoxaban can be an alternative to warfarin in patients with venous thromboembolism is unclear. MethodsIn a randomized, double-blind, noninferiority study, we randomly assigned patients with acute venous thromboembolism, who had initially received heparin, to receive edoxaban at a dose of 60 mg once daily, or 30 mg once daily (e.g., in the case of patients with creatinine clearance of 30 to 50 ml per minute or a body weight below 60 kg), or to receive warfarin. Patients received the study drug for 3 to 12 months. The primary efficacy outcome was recurrent symptomatic venous thromboembolism. The principal safety outcome was major or clinically re…

MESH: Pulmonary EmbolismMale[SDV]Life Sciences [q-bio]Kaplan-Meier Estimate030204 cardiovascular system & hematologylaw.inventionMESH: Venous Thromboembolismchemistry.chemical_compound0302 clinical medicineRandomized controlled trialEdoxabanlawMESH: Double-Blind Method030212 general & internal medicineMESH: WarfarinMESH: AgedMESH: Middle AgedHazard ratioGeneral MedicineVenous ThromboembolismMiddle AgedThrombosis3. Good healthPulmonary embolismAnesthesiaFemaleAnticoagulants EdoxabanMESH: HemorrhageAndexanet alfamedicine.drugMESH: EnoxaparinHemorrhageMESH: AnticoagulantsMESH: Drug Administration ScheduleDrug Administration Schedule03 medical and health sciencesDouble-Blind MethodAged; Anticoagulants; Double-Blind Method; Drug Administration Schedule; Enoxaparin; Female; Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Pulmonary Embolism; Venous Thromboembolism; WarfarinmedicineHumansEnoxaparinAdverse effectMESH: Kaplan-Meier EstimateAgedMESH: Humansbusiness.industryWarfarinAnticoagulantsmedicine.diseaseMESH: MalechemistryWarfarinbusinessPulmonary EmbolismMESH: FemaleNew England Journal of Medicine
researchProduct

Metal complexes of phenobarbituric acid. Chelating behavior of the phenobarbiturate ring. Anticonvulsant properties of the K2[Cu(N-methylphenobarbitu…

1992

Abstract Na2Ni(phenobarbiturato)4·3H2O, Na2Ni3(phenobarbiturato)2(OH)6·4H2O, and NaZn(phenobarbiturato)2(OH)·H2O derivatives were prepared from Ni(II) and Zn(II) and phenobarbital. The Na2Ni(phenobarbiturato)4·3H2O complex is diamagnetic and isostructural with the complex previously reported, Na2Cu(phenobarbiturato)4, suggesting a square-planar environment around the Ni(II) ion. The DMF solutions of this complex show the existence of two species. The EPR spectra of the Cu(II) doped complex show the hyperfine and superhyperfine structures. The covalence parameters α2, β2, and δ2 show a strong bonding in the equatorial plane and suggests the formation of a [CuN4] chromophore. The anticonvulsa…

Magnetic Resonance SpectroscopyStereochemistryMephobarbitalBiochemistrylaw.inventionIonInorganic ChemistryMetalStructure-Activity RelationshiplawSeizuresAnimalsChelationIsostructuralElectron paramagnetic resonanceHyperfine structureChelating AgentsElectroshockMolecular StructureChemistryElectron Spin Resonance SpectroscopyChromophoreCrystallographyCovalent bondMetalsvisual_artPhenobarbitalvisual_art.visual_art_mediumAnticonvulsantsCopperJournal of inorganic biochemistry
researchProduct